Twi Biotechnology Inc.
- Address
- 8 F, Lane 221, No 41 Gangqian Rd
Sponsor Overview
Specializations
Skin Fragility Disorders
Twi Biotechnology Inc. is involved in clinical research focused on generalized epidermolysis bullosa simplex, a rare inherited blistering skin disorder affecting both adult and pediatric patients.
- Generalized epidermolysis bullosa simplex
- Inherited skin fragility
- Blistering dermatoses
The company’s research interest centers on conditions marked by fragile skin and recurrent blistering, with attention to severe and intermediate disease forms.
Paediatric and Adult Dermatology
The sponsor’s clinical activity includes patients from infancy through adulthood, reflecting interest in paediatric dermatology and adult dermatology within the same rare disease setting.
- Paediatric patients
- Adult patients
- Age-inclusive rare disease care
This range highlights therapeutic attention to lifelong management of a chronic genetic skin condition across different age groups.
Topical Therapeutics
Research supported by the sponsor includes topical treatment development for symptomatic management of skin lesions associated with generalized EBS.
- Topical ointment therapy
- Local skin treatment
- Lesion-directed therapy
The therapeutic focus is on dermatologic interventions intended for direct application to affected skin areas in a rare inherited disorder.
Rare Disease Clinical Development
The company is active in rare disease research with a multicountry clinical program spanning multiple collaborating sites across Asia, Europe, and other regions.
- Rare genetic disease
- Multinational clinical research
- Cross-border patient access
Its clinical interests lie in advancing treatment options for a low-prevalence inherited condition with specialized dermatologic needs.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Efficacy and Safety Evaluation of Diacerein 1% Ointment in Generalized Epidermolysis Bullosa Simplex: A Randomized, Double-Blind, Vehicle-Controlled Study |  Austria Belgium France Greece Ireland Italy Poland Spain | Recruiting |
Data & Insights
This sponsor works with 1 molecule, of which 1 is not being studied by other sponsors.
This sponsor has worked with 15 sites across their trial portfolio.
Therapeutic Focus
- 1.Skin and Connective Tissue Diseases1 trial247 other sponsors
Partnered Research Centres
15 centres- Address
- Dragoumi Ionos 5 I, 161 21 Athens
- Address
- Largo Del Pozzo 71, 41124 Modena
- Address
- Via Pietro Albertoni 15, 40138 Bologna
- Address
- Cooley Road, Crumlin, D12 PN40 Dublin
- Address
- Al. Tadeusza Kościuszki 93, 90-436 Lodz
- Address
- Via Francesco Sforza 28, 20122 Milan
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Twi Biotechnology Inc..
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.